The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
76 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $14,496,359 in first-year total cost, median $161,500.
Most frequent study sections
- Chronic Dysfunction and Integrative Neurodegeneration Study Section[CDIN]18
- Cellular and Molecular Biology of Glia Study Section[CMBG]8
- Cellular and Molecular Biology of Neurodegeneration Study Section[CMND]7
- Clinical Neuroscience and Neurodegeneration Study Section[CNN]5
- Cellular Mechanisms in Aging and Development Study Section[CMAD]4
Most frequent institutions
- ROSKAMP INSTITUTE, INC.5
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI4
- UNIVERSITY OF MARYLAND BALTIMORE3
- BAYLOR COLLEGE OF MEDICINE2
- CASE WESTERN RESERVE UNIVERSITY2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Role of mitochondrial Complex I deficiency in Alzheimer disease and dementia1R03AG084940-01 | POLSTER, BRIAN M | UNIVERSITY OF MARYLAND BALTIMORE, MD | $311,000 | NOMD |
| 2024 | Development of Novel γ-Secretase PET Agents for the Exploration of AD Pathology1R03AG081968-01A1 | XU, YULONG | MASSACHUSETTS GENERAL HOSPITAL, MA | $167,000 | EITN |
| 2024 | Role of Y-family DNA polymerase Pol kappa in aging and Alzheimer's disease1R03AG081828-01A1 | PAUL, SHILPI | PENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA | $166,800 | CMAD |
| 2024 | Induction of Neutrophil Extracellular Traps by Beta-Amyloid Deposits in Cerebral Amyloid Angiopathy1R03AG085082-01 | SCHRADER, JOSEPH M | UNIVERSITY OF RHODE ISLAND, RI | $157,500 | ANIE |
| 2024 | Enhancer RNAs and enhancer-centric gene regulatory networks in vascular dementia1R03AG084918-01 | DHARAP, ASHUTOSH | UNIVERSITY OF SOUTH FLORIDA, FL | $150,000 | BINP |
| 2024 | New biomarkers for early Alzheimer's diagnosis and tauopathy differentiation1R03AG085058-01 | WU, LING | NORTH CAROLINA CENTRAL UNIVERSITY, NC | $150,000 | CNN |
| 2023 | Daily Memory Lapses and Sympathetic-Cardiovascular Dysfunction: Pathways to Prevention of Alzheimer's Disease and Related Dementias (ADRD)1R03AG083323-01 | GREANEY, JODYJANG, HEEJUNG | CLEMSON UNIVERSITY, SC | $318,574 | MESH |
| 2023 | Patient specific computational modeling of fluid-structure interactions of cerebrospinal fluid for biomarkers in Alzheimer's disease1R03AG081836-01 | FILLINGHAM, PATRICK | UNIVERSITY OF WASHINGTON, WA | $303,614 | ZRG1 |
| 2023 | Behavioral and physiological measurements of hearing in mouse models of Alzheimer's Disease1R03AG081747-01 | DENT, MICHEAL LLAUER, AMANDA M. | STATE UNIVERSITY OF NEW YORK AT BUFFALO, NY | $177,156 | AUD |
| 2023 | Integrative genomic analysis of adenosine-to-inosine editing in Alzheimer's disease1R03AG080170-01 | BREEN, MICHAEL S | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $166,240 | GHD |
| 2023 | Influence of APOE4 genotype on microglial pathobiology and tau pathology after repetitive mTBI1R03AG080415-01 | OJO, JOSEPH O | ROSKAMP INSTITUTE, INC., FL | $163,440 | CMBG |
| 2023 | Bacterial triggers of neural inflammation.1R03AG080175-01 | BURBERRY, AARON | CASE WESTERN RESERVE UNIVERSITY, OH | $161,000 | CDIN |
| 2023 | Developing and Validating a Novel Tau Toxicity Model in the Budding Yeast1R03AG080423-01 | DANG, WEIWEI | BAYLOR COLLEGE OF MEDICINE, TX | $160,000 | CMAD |
| 2023 | Structural characterization of APP family proteins1R03AG081787-01 | PETROU, VASILEIOS I | RUTGERS BIOMEDICAL AND HEALTH SCIENCES, NJ | $157,000 | MSFB |
| 2023 | A Breakdown of Memory Replay: Elucidating the Relationship Between Sleep and Alzheimer's Disease from Surface Electroencephalography1R03AG080427-01 | MCCONNELL, BRICE V | UNIVERSITY OF COLORADO DENVER, CO | $155,500 | CNN |
| 2023 | Reduced allelic dosage of CLP1 attenuates cognitive dysfunction and pathological burden in transgenic mouse models of Alzheimer’s disease1R03AG080287-01 | SCHAFFER, ASHLEIGH E | CASE WESTERN RESERVE UNIVERSITY, OH | $155,205 | CDIN |
| 2023 | Effects of mild traumatic brain injury in a mouse model of cerebral amyloid angiopathy1R03AG081865-01 | ROBISON, LISA SUZANNE | NOVA SOUTHEASTERN UNIVERSITY, FL | $154,000 | CDIN |
| 2023 | Cerebrovascular endothelial cilia in the pathogenesis and therapy of Alzheimer's disease1R03AG080418-01 | ABOUALAIWI, WISSAM | UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS, OH | $149,050 | ZRG1 |
| 2023 | Astrocytic exocytosis of ATP in amyloid pathology and Alzheimer's disease1R03AG083363-01 | CAI, WEIKANG | NEW YORK INST OF TECHNOLOGY, NY | $119,000 | CMBG |
| 2022 | Assessing effects of manipulation of expression of kinesins in a mouse modelof Alzheimer's disease1R03AG073870-01A1 | PUTHANVEETTIL, SATHYA | UNIVERSITY OF FLORIDA, FL | $386,400 | CDIN |
| 2022 | Deciphering Ang2/Tie2 signaling regulation of BBB disruption and neuroinflammation in Alzheimers disease1R03AG073833-01A1 | KIM, MINAH | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $328,833 | ZRG1 |
| 2022 | Investigation of sirtuin 1 expression in mice model of Alzheimer's disease over age1R03AG076389-01 | WANG, CHANGNING | MASSACHUSETTS GENERAL HOSPITAL, MA | $323,760 | CDIN |
| 2022 | Role of pericytes in postoperative neurocognitive disorder during aging1R03AG078882-01 | YANG, TING | DUKE UNIVERSITY, NC | $322,000 | CDIN |
| 2022 | DNA Nanostructures as siRNA Delivery Vehicles for Alzheimer's Therapy1R03AG076599-01 | CHANDRASEKARAN, ARUN RICHARD | STATE UNIVERSITY OF NEW YORK AT ALBANY, NY | $312,417 | ZRG1 |
| 2022 | Analysis of Nrf1 pathway in Alzheimer's Disease1R03AG073884-01 | RADHAKRISHNAN, SENTHIL KUMAR | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $310,500 | CMND |
| 2022 | Ffar4 attenuates neuroinflammation in Alzheimer's Disease1R03AG078686-01 | MURPHY, KATHERINE A | UNIVERSITY OF MINNESOTA, MN | $310,000 | CDIN |
| 2022 | Development of a novel gene therapy for the treatment of tauopathy1R03AG075597-01A1 | KHAN, MOHAMMAD MOSHAHIDPOURMOTABBED, TAYEBEH | UNIVERSITY OF TENNESSEE HEALTH SCI CTR, TN | $308,000 | CDIN |
| 2022 | Directed evolution of tissue inhibitor of metalloproteinase 3 (TIMP-3) to develop novel Alzheimer’s disease (AD) therapeutics1R03AG070511-01A1 | RAEESZADEH SARMAZDEH, MARYAM | UNIVERSITY OF NEVADA RENO, NV | $299,975 | DDNS |
| 2022 | Contributions of Iron Regulatory Proteins and Ferroptosis to Neurodegeneration1R03AG077299-01 | MONTGOMERY, MCKALE | OKLAHOMA STATE UNIVERSITY STILLWATER, OK | $292,657 | NOMD |
| 2022 | Time-restricted feeding (TRF) for prevention of age-related vascular cognitive impairment and dementia1R03AG070479-01A1 | TARANTINI, STEFANO | UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, OK | $290,000 | CDIN |
| 2022 | Cerebrovascular contributions to cognitive impairment in Lewy body dementias1R03AG075408-01 | RYMAN, SEPHIRA | LOVELACE BIOMEDICAL RESEARCH INSTITUTE, NM | $181,000 | CNN |
| 2022 | Mechanisms underlying glutamate dyshomeostasis in Alzheimer's disease1R03AG070766-01A1 | ROSENBERG, PAUL ALLEN | BOSTON CHILDREN'S HOSPITAL, MA | $177,000 | SYN |
| 2022 | THE ROLE OF PTEN IN MICROGLIAL PATHOBIOLOGY AFTER EXPOSURE TO REPETITIVE MILD TBI1R03AG078772-01 | OJO, JOSEPH O | ROSKAMP INSTITUTE, INC., FL | $163,440 | CMBG |
| 2022 | The role of PPARγ in microglia pathobiologyafter exposure to repetitive mild traumatic brain injury1R03AG075365-01 | OJO, JOSEPH O | ROSKAMP INSTITUTE, INC., FL | $163,439 | CMBG |
| 2022 | Understanding how human brain vascular cells mediate genetic risk for Alzheimer's disease1R03AG079029-01 | YANG, ANDREW CHRIS | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $161,500 | GHD |
| 2022 | Dysfunctional Orexin-Regulated Neural Circuits in Alzheimer's Disease1R03AG070454-01A1 | GOFORTH, PAULETTE B. | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $156,000 | CDIN |
| 2022 | Targeting Type I IFN signaling to promote recovery following brain trauma in aged animals1R03AG070532-01A1 | BARRETT, JAMES PAUL | UNIVERSITY OF MARYLAND BALTIMORE, MD | $154,500 | ZRG1 |
| 2022 | Cognitive decline in aging and AD: neuroprotection by hypermyelination in FusOLcKO1R03AG072218-01A1 | CAMBI, FRANCA | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $154,146 | ZRG1 |
| 2022 | Oxylipins, aging and Alzheimer’s disease1R03AG075465-01 | LEE, KIN SING STEPHEN | MICHIGAN STATE UNIVERSITY, MI | $152,718 | CMAD |
| 2022 | Deep brain stimulation of the Nucleus Basalis of Meynert: the role of stimulation parameters in neurogenesis and cognitive recovery1R03AG075637-01 | KUMBHARE, DEEPAK | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $1 | CNNT |
| 2021 | Contribution of peripheral immune dysregulation to Alzheimer's disease1R03AG070506-01 | WANG, JUN | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $338,416 | CDIN |
| 2021 | Cerebral vascular calcium signaling in diabetic Alzheimer's disease-related dementias1R03AG070784-01 | WANG, YONG-XIAO | ALBANY MEDICAL COLLEGE, NY | $326,000 | BINP |
| 2021 | Enduring effects of high estrogen on Alzheimer's disease1R03AG070687-01 | SUN, ZHENG | BAYLOR COLLEGE OF MEDICINE, TX | $320,000 | ZRG1 |
| 2021 | The impact of reduced blood flow early in Alzheimer's disease on neuronal function.1R03AG070507-01 | O'HERRON, PHILIP | AUGUSTA UNIVERSITY, GA | $308,000 | CDIN |
| 2021 | Toxicity mechanisms of Aβ42 and Tau in aged cells1R03AG070478-01A1 | ZHOU, CHUANKAI | BUCK INSTITUTE FOR RESEARCH ON AGING, CA | $194,000 | CMAD |
| 2021 | Impact of apolipoprotein E isoforms on brain lipoproteins1R03AG070480-01 | MELCHIOR, JOHN | BATTELLE PACIFIC NORTHWEST LABORATORIES, WA | $192,621 | CDIN |
| 2021 | Second Generation Gene Therapy for APOE4 Homozygous Individuals at High Risk for Alzheimer's Disease1R03AG070738-01 | STILES, KATIE M | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $169,500 | CMND |
| 2021 | Exploring autophagy as a target for Alzheimer's Disease1R03AG072020-01 | LAZARUS, MICHAEL BLOCK | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $169,375 | CMND |
| 2021 | TYROBP/DAP12: a hub protein linking Alzheimer's disease, microglia, and gut microbiome.1R03AG070710-01A1 | HAURE-MIRANDE, JEAN-VIANNEY | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $169,209 | CMBG |
| 2021 | Understanding Social Communication Abilities in Individuals with Alzheimer's Disease1R03AG072236-01 | PAEK, EUN JINYOON, SI ON | UNIVERSITY OF TENNESSEE HEALTH SCI CTR, TN | $166,229 | LCOM |
| 2021 | Use of super-resolution microscopy to visualize the interaction between Alzheimer therapeutic antibodies and Aβ aggregates1R03AG070709-01 | AMIN, LADAN | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $165,000 | BPNS |
| 2021 | Targeting P21-Highly-Expressing Senescent Cells In Vivo for Improving Cognitive Function in the Alzheimers Diseases1R03AG072374-01 | XU, MING | UNIVERSITY OF CONNECTICUT SCH OF MED/DNT, CT | $164,000 | CDIN |
| 2021 | The effects of APOE4 on carnitine/acylcarnitine mediated bioenergetic deficits in Alzheimer's disease1R03AG070540-01 | ABDULLAH, LAILA | ROSKAMP INSTITUTE, INC., FL | $162,000 | NOMD |
| 2021 | Influence of APOE genotype on cerebrovascular cell pathobiology in AD, and the contribution of microglia inflammation1R03AG073829-01 | OJO, JOSEPH O | ROSKAMP INSTITUTE, INC., FL | $161,991 | CMBG |
| 2021 | The brain cholesterol interactome1R03AG070428-01 | FERRIS, HEATHER | UNIVERSITY OF VIRGINIA, VA | $161,500 | CMBG |
| 2021 | Hematopoietic Stem Cell Transplantation Combined with CSF1 Inhibition to Attenuate the Pathogenesis of Alzheimer's Disease1R03AG070421-01 | SUNG, ANTHONY | DUKE UNIVERSITY, NC | $161,000 | CDIN |
| 2021 | Continuing Tool Development for Longitudinal Network Analysis: Enriching the Diagnostic Power of Disease-Specific Connectomic Biomarkers by Deep Graph Learning1R03AG070701-01 | WU, GUORONG | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $158,733 | EITN |
| 2021 | Toward precision medicine: modulation of ABCA7 associated risk of Alzheimer's disease by ancestry1R03AG070512-01 | LYSSENKO, NICHOLAS | TEMPLE UNIV OF THE COMMONWEALTH, PA | $158,500 | ZRG1 |
| 2021 | Impact of APOE Christchurch mutation on amyloid burden and tau pathology1R03AG073879-01 | MOON, YOUNGHYE | INDIANA UNIVERSITY INDIANAPOLIS, IN | $158,500 | ZRG1 |
| 2021 | Developing a screening platform to identify inhibitors of pathological self-assembly of Tau1R03AG070510-01 | BANERJEE, PRIYA R. | STATE UNIVERSITY OF NEW YORK AT BUFFALO, NY | $157,747 | BPNS |
| 2021 | Imaging the metabolic and phagocytic landscape of microglia in Alzheimer’s disease1R03AG071791-01 | HEILSHORN, SARAH C | STANFORD UNIVERSITY, CA | $157,525 | CMBG |
| 2021 | Define molecular events driving selective neuronal death in multiple neurodegenerative diseases by snRNA-seq1R03AG070474-01 | XU, JINBINZHAO, GUOYAN | WASHINGTON UNIVERSITY, MO | $157,500 | CDIN |
| 2021 | The Mechanical Properties of the Brain and Their Effect on Alzheimer's Disease1R03AG073834-01 | GU, LUO | JOHNS HOPKINS UNIVERSITY, MD | $156,481 | BNVT |
| 2021 | A novel experimental model of chronic stress and hypertension for studying dementia-related neurovascular dysfunction in the hippocampus1R03AG072016-01 | ERDOS, BENEDEK | UNIVERSITY OF VERMONT & ST AGRIC COLLEGE, VT | $156,000 | ZRG1 |
| 2021 | Prevalence and impact of cerebral anatomical variations: a risk factor for cognitive decline?1R03AG070469-01 | BARNES, JILL NICOLE | UNIVERSITY OF WISCONSIN-MADISON, WI | $155,000 | CNN |
| 2021 | Development of isogenic iPSC cell lines expressing tauopathy-related PERK risk variants to study homeostatic control of protein levels during ER stress1R03AG070415-01 | YUAN, SHAUNA H | UNIVERSITY OF MINNESOTA, MN | $154,751 | NOMD |
| 2021 | Role of aging-dependent changes in neuronal sub-types in development of radiotherapy-induced cognitive decline in the elderly population1R03AG070586-01A1 | SABIRZHANOV, BORISSTOICA, BOGDAN ADRIAN | UNIVERSITY OF MARYLAND BALTIMORE, MD | $154,500 | CDIN |
| 2021 | Role of age-dependent repetitive element transcript dysregulation in Alzheimers disease1R03AG070562-01A1 | LAROCCA, THOMAS | COLORADO STATE UNIVERSITY, CO | $152,000 | CMND |
| 2021 | Recovery of Synaptic Dysfunction and Memory Loss in Alzheimer's Disease by Selective Co-Activation of Nicotinic Acetylcholine Receptors1R03AG072102-01A1 | KIM, SEONIL | COLORADO STATE UNIVERSITY, CO | $152,000 | NCF |
| 2021 | Super-Resolution Tau PET Imaging for Alzheimer's Disease1R03AG070750-01 | DUTTA, JOYITA | UNIVERSITY OF MASSACHUSETTS LOWELL, MA | $151,980 | CNN |
| 2021 | Effects of cell-type specific brain stimulation in Alzheimer's model mice1R03AG070517-01 | SATO, TAKASHI | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $150,500 | CDIN |
| 2021 | Investigation of the role of glia cells in Alzheimers pathogenesis in a functional human-based in vitro model1R03AG070514-01 | GUO, XIUFANG | UNIVERSITY OF CENTRAL FLORIDA, FL | $148,185 | BNVT |
| 2021 | Characterizing upstream regulators of glucosylceramide metabolism for Parkinson's disease and Lewy Body Dementia1R03AG070492-01 | NORTH, BRIAN J. | CREIGHTON UNIVERSITY, NE | $145,500 | CMND |
| 2021 | Deciphering the effect of human microbiota on Alzheimer's disease using C. elegans models of protein conformational diseases1R03AG070580-01 | CZYZ, DANIEL MILOSZ | UNIVERSITY OF FLORIDA, FL | $76,250 | CMND |
| 2021 | Understanding the link between FAIM expression and Alzheimer’s disease and related dementias1R03AG072148-01 | KAKU, HIROAKI | WESTERN MICHIGAN UNIV SCHOOL OF MEDICINE, MI | $75,500 | CMND |
| 2021 | Contribution of Endothelial Changes and Increased Cardiovascular Risk to Alzheimer's Disease Pathogenesis1R03AG070541-01A1 | CLEUREN, AUDREY | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $1 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.